Invention Grant
US09119852B2 Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline
有权
包含2,3-二甲基-6-（N，N-二甲基氨基乙基）-6H-吲哚并（2,3-b）喹喔啉的治疗疱疹病毒感染的药物制剂
- Patent Title: Pharmaceutical formulation for treating herpes virus infection comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b) quinoxaline
- Patent Title (中): 包含2,3-二甲基-6-（N，N-二甲基氨基乙基）-6H-吲哚并（2,3-b）喹喔啉的治疗疱疹病毒感染的药物制剂
-
Application No.: US13984105Application Date: 2012-02-17
-
Publication No.: US09119852B2Publication Date: 2015-09-01
- Inventor: Mohammed Homman , Jan Bergman
- Applicant: Mohammed Homman , Jan Bergman
- Agency: Young & Thompson
- Priority: EP11154979 20110218
- International Application: PCT/EP2012/052763 WO 20120217
- International Announcement: WO2012/110631 WO 20120823
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D241/38 ; A61K9/00 ; A61K9/06 ; A61K45/06
Abstract:
A pharmaceutical composition for topical administration including 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline (B-220) or a pharmaceutically acceptable salt thereof in a pharmaceutically acceptable carrier. The composition is useful for the treatment of herpes virus infections of the skin or mucous membranes in a mammal subject.
Public/Granted literature
- US20130310392A1 PHARMACEUTICAL FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING B220 Public/Granted day:2013-11-21
Information query
IPC分类:
